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Abstract 
 
Astronauts have begun to spend increasingly longer periods in space, putting themselves in foreign 
environments in order to explore the unknown. Space radiation is one of the largest health risks 
faced by astronauts on their missions. The space radiation environment has the ability to cause 
high levels of irreversible damage. Multiple sources of charged particle radiation exist in the space 
environment that may increase risk of carcinogenesis, degeneration of bodily tissue (e.g. 
gastrointestinal, cardiovascular, or pulmonary), acute radiation syndromes, and acute and late 
central nervous system (CNS) disorders.  In order to help inform an understanding of the risk of 
degenerative CNS disease due to radiation exposure, an initial step is presented here to develop 
an adverse outcome pathway from radiation exposure focused on Alzheimer’s disease. 
 
 
Introduction 
 
Astronauts, even within the safety of a spacecraft, are subject to many health risks 
associated with spaceflight.  Of primary interest to this work is the space radiation environment.  
Outside the spacecraft, a low intensity background of high charge and energy particles called 
galactic cosmic rays (GCR) permeates the Solar System.  GCR are known to originate in 
supernovae throughout our galaxy (Ackermann et al., 2013).  The GCR environment consists of 
fully ionized nuclei with ions covering the entire periodic table.  Ions with lower atomic number 
tend to be more abundant in the GCR environment, however details of the nuclear physics provide 
some exceptions (Simpson, 1983). Because GCR are comprised of charged particles, the magnetic 
field of the sun modulate the low energy portion (below approximately 3 GeV/n) of the GCR 
spectrum. Both the complex nuclear structure and the high energy characteristics of the GCR 
environment make standard radiation shielding practices ineffective and astronauts have elevated 
radiation exposure within the interior of spacecraft. 
In addition to GCR, the radiation environment of space can be enhanced by solar energetic 
particles (SEP).  SEP, as the name suggest, originate from the sun during either solar flares or 
coronal mass ejections (Reames, 2013). SEP, which are primary composed of protons, are sporadic 
events that can significantly increase the intensity of the radiation environment of space.  
Fortunately, SEP tend to have an energy spectrum which is dominated at energies for which 
moderate amounts of spacecraft shielding significantly attenuate the event within a spacecraft 
(Townsend et al., 2018). 
The health risks associated with the space radiation environment are of concern for both 
the in-flight mission success and the long-term health of astronauts.  A major risk for the long term 
health of astronauts is the increase in mortality and morbidity from carcinogenesis due to space 
radiation exposure (Huff et al., 2016).  The risk for cancer in terrestrial radiation-exposed cohorts 
is well documented and the risk is thought to also apply to the radiation environment of space 
(Cucinotta et al., 2013). Acute radiation syndromes are also well documented in terrestrial 
radiation exposure events (Hall & Garcia, 2006). In addition, space radiation has been shown to 
increase the incidence of cataracts in astronauts (Cucinotta et al., 2001).  The evidence for other 
space radiation-induced health decrements comes mainly from animal studies. These health 
decrements include acute and late central nervous system (CNS) disorders, and other degenerative 
effects in human tissues such as cardiovascular disease or gastrointestinal dysfunction (Nelson et 
al., 2016; Patel et al., 2016).  
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The acute CNS consequences resulting from space radiation are somewhat understood, as 
previous neuroscientific studies have demonstrated evidence of cognitive deficits in domains such 
as learning and association, facial emotional recognition, logical reasoning, executive function, 
and risk assessment, lasting up to six months after space radiation exposure (Garrett-Bakelman et 
al., 2019). These acute neurocognitive deficits have been demonstrated not only in rat models, but 
also in human ones, from data gathered from both Chernobyl residents (World Health 
Organization, 2006) and tests done with astronauts (Garrett-Bakelman, et al., 2019) after their 
times in space. While consistent with previous findings, confounding factors for both Chernobyl 
residents and Astronauts may be occurring.  In the case of correlation between mortality due to 
cerebrovascular events and radiation exposure, results have been mixed. The study by Azizova et 
al. (2011) of Mayak workers showed correlation between radiation exposure and mortality due to 
cerebrovascular events, while the meta-study by Little (2016) of terrestrial radiation exposures 
found that the excess relative risk for cerebrovascular disease per Sievert was significant but highly 
heterogeneous.  
On the other hand, the long-term effects of extended exposure to space radiation are not as 
well studied. A small viable population size in addition to a lack of understanding about the 
development of neurodegenerative disorders in general have contributed to the small amount of 
data available for true analyses of the possibility for neurodegenerative disorders as a result of 
space radiation. It is, however, fundamental that these risks are thoroughly evaluated and 
understood for the future of space travel and exploration. Therefore, this report is a summary of 
some of the neurophysiological changes that could lead to Alzheimer’s disease as a result of low 
dose ionizing radiation. Included is an Adverse Outcome Pathway (AOP), a structured diagram 
used in environmental science and toxicology to map out events that occur after exposure to a 
foreign agent. An introduction to AOP can be found at aopwiki.org. 
 
Neuroanatomy and Neuropathology of Alzheimer’s Disease (AD)  
 
According to the Center for Disease Control, Alzheimer’s disease (AD) is the most 
common type of dementia worldwide (CDC, 2019). The Alzheimer’s Association states that more 
than 5.8 million Americans live with the disease-- this number is projected to rise to 14 million by 
2050 (Alzheimer’s Association, 2019). The neurodegenerative disorder is characterized by 
memory loss, problems with language, and spatial disorientation. The progression of the condition 
leads to gradual worsening of the aforementioned cognitive deficits and the emergence of other 
symptoms: decrease in attention span, decrease in executive function, and loss of working memory. 
Patients have a post-diagnosis life expectancy of anywhere between two and twenty years, 
depending on both the individual and the stage of AD at the time of diagnosis. Associated with the 
process of aging, AD’s onset is usually after 65 years of age. (This is with the exception of patients 
with early-onset AD, whose dementia-like symptoms begin at around 40-50 years of age.  Early-
onset AD patients account for a minority (5-10%) of AD diagnoses (Campion et al., 1999).) 
 The cause of AD is unknown, but one of the most widely accepted theories for the 
syndrome is known as the Beta-Amyloid (Aβ) hypothesis (Bear et.al, 2009). Aβ proteins are 
formed as a byproduct of the amyloid precursor protein (APP), and though Aβ proteins’ roles 
remain mostly unidentified, their formation and the plaques they leave behind begin a mechanism 
that leads to the cognitive and behavioral deficits that are diagnosed as AD. However, this theory 
of AD onset is incomplete due to its inability to account for the relation between Aβ plaques and 
neurofibrillary tangles, the latter of which are created due to hyperphosphorylation of tau proteins. 
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In post-mortem examinations, AD patients exhibit excess buildup of Aβ plaques, tau tangles, and 
gross atrophy of hippocampal neurons. However, there exists no known relationship between Aβ 
protein and development of tau tangles. Moreover, there remains no proven causative link between 
Aβ plaque buildup, neurofibrillary tangle formation, and AD progression, as medications and 
interventions designed to block Aβ accumulation and tangle creation have been unsuccessful in 
halting or even slowing the progression of the disorder (Kametani & Hasegawa, 2018). 
The hippocampus, found bilaterally in the medial temporal lobe, is the center for episodic 
memories and spatial awareness. Of all the parts of the brain, it is the first to be affected by AD, 
and its atrophy leads to the hallmark symptoms of AD. Lesions to the hippocampus cause 
locational disorientation and memory loss, specifically in the module of episodic memory. These 
aforementioned memories are a type of long-term memory that require associations to time and 
place of the event, often requiring personal or emotional connection. Conscious recollection is a 
sign of proper retrieval of the episodic memory, and loss of this ability exhibits itself behaviorally 
and symptomatically as dementia.  
The hippocampus is also important for a few other reasons. For one, it contains the dentate 
gyrus, one of the only sites of neurogenesis in the human brain (the other area designated for 
neuron formation is around the olfactory bulb). The formation of neurons in the human brain is 
mostly complete by birth. Generation rate is dependent on lifestyle choices such as physical 
exercise, (which increases neurogenesis), and smoking, (which decreases neuron regeneration), as 
well as neural processes like learning. It should also be noted that neurogenesis rate decreases as 
a result of stress and aging.  
Besides neurogenesis, long term potentiation (LTP) also occurs within the hippocampus. 
LTP occurs as a result of learning and is a process that physically changes the shape of neurons 
due to strong activation of NMDA receptors. LTP’s partner, long term depression (LTD), weakens 
synapses post-LTP. The synergistic relationship between LTD and LTP leads to successful long-
term encoding of information that can last for years. In AD rat models, Aβ-infusion has been linked 
to impairment of LTP, possibly contributing to the learning and memory problems found in AD 
patients (Itoh et al., 1999). 
 
Oxidative Stress   
 
Besides the Aβ hypothesis, other theories have also arisen regarding the onset of AD. 
Though nothing is definitive, oxidative stress has been found to be linked to the progression of 
AD. Oxidative stress refers to the amalgamation of damage done by reactive oxygen species (ROS) 
and other free radicals to a biological system. The most common examples of ROS are superoxide 
(O2-) and hydrogen peroxide (H2O2). ROS are formed naturally as byproducts of cellular 
metabolism. They are critical to the homeostatic environment—lower levels of ROS can disrupt 
cellular processes such as cell division, and on the opposite side of the spectrum, raising levels 
past equilibrium can cause significant amounts of cellular and tissue damage (Finkel et al., 2000). 
In a homeostatic environment, intracellular antioxidants such as Vitamins A, C, and E are created 
by mitochondrial enzymes and hold the role of reducing reactive species, thus eliminating the 
negative effects of oxidative stress.  
 ROS, particularly superoxide (O2-), will also react with nitric oxide (NO) to form 
peroxynitrite (ONOO-). Produced by nitric oxide synthase (NOS), NO plays an important role in 
cellular signaling, vasodilation, and immune response (Drew & Leeuwenburgh, 2002), as well as 
in acting as a neurotransmitter. Combined with a free radical, however, the product, ONOO-, is a 
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strong oxidant and reactive nitrogen species (RNS). In high amounts, peroxynitrite is classified as 
a neurotoxin, leading to apoptotic or necrotic neuronal cell damage (Bonfoco et al., 1995).  
 The free radical theory of aging states that biological aging is a result of ROS and RNS 
induced oxidative stress. The theory hypothesizes that ROS/RNS cause damage that accumulates 
and leads to aging and age-dependent diseases. ROS and RNS cause deletion in mitochondrial 
DNA (mtDNA), leading not only to apoptosis but also to inefficiencies in mitochondria that leads 
to further generation of ROS (Indo et al., 2007). ROS and RNS can also cause damage to cellular 
signaling pathways, lipids, and proteins, possibly leading to an increase in rate of onset for ageing 
and age-dependent disorders (Finkel & Holbrook, 2000). 
 Neurons appear especially susceptible to the perils of oxidative stress for a few reasons. 
Firstly, free radicals wreak havoc on poly-unsaturated fatty acids (PUFAs) and other redox-
sensitive proteins. Neuronal membranes contain a high percentage of PUFAs, specifically 
arachidonic and docosahexaenoic acid, and these lipids’ peroxidation is a biomarker for AD 
development. Patients with mild cognitive impairment (MCI), a stage of cognitive decline between 
normal aging and the dementia symptom of AD, show an increase of lipid peroxidation levels in 
the temporal lobe (Pratico & Sung, 2004). The same increase in lipid peroxidation is found in AD 
patient brains (Azzam et al., 2012). 
Neuronal PUFAs aside, the brain has another inherent quality that leads to its weakness to 
ROS and RNS. Due to its complexity, the brain and its normal operations require high levels of 
cellular metabolism due to its high demand for energy. This particular ATP-bound stipulation calls 
for high levels of oxygen and leads to higher production of ROS within neuronal mitochondria. 
High levels of cellular respiration, dependent almost solely on the electron transport chain (ETC), 
can contribute to production of free radicals (Liu et al., 2002). It is believed that inefficiencies 
within the electron transport chain in neuronal mitochondria is what leads to overproduction of 
free radicals, specifically the activity of cytochrome-c oxidase and its relationship with complex 4 
(Yves, 2000).  
Lastly, the brain lacks the antioxidant enzymes in neuronal mitochondria, leading to higher 
vulnerability to the effects of ROS. Neurons possess lower levels of catalase when compared to 
other body tissues, which could contribute to sensitivity to oxidative stress (Cobley et al., 2018).  
Recent studies have found significant correlation between increased levels of ROS and 
development of neurodegenerative disorders such as AD. It is hypothesized that the free hydroxyl 
radical, hydrogen peroxide, peroxynitrite, and nitric oxide are involved in AD (Yves, 2000).  
 
Neuroinflammation  
 
 Neuroinflammation results from infection, brain injuries, and general damage to the brain. 
Chronically, it is the continuous activation of glial cells and other immune responses in the brain. 
In recent years, chronic neuroinflammation has become the subject of studies related to 
Alzheimer’s due to its presence in the CNS in AD patients (Kinney et al, 2018). Central to the 
process of neuroinflammation are microglia and astrocytes, glial cells that support neuronal 
function and protect neuronal processes.  
 Microglial cells support and protect neurons in the CNS and are part of the endogenous 
immune response in the brain. These neural macrophages scavenge for molecules, undergo 
phagocytosis, and participate in extracellular signaling that triggers activation of other 
macrophages both inside and outside the brain. Microglia will actively move through their areas 
regularly, searching for foreign material. This “foreign material” includes Aβ plaques, and 
microglia will surround and engulf said plaques upon contact, leading to clumps of microglia 
 5 
 
 
around sites of Aβ deposition (Tuppo & Arias, 2005). It should also be noted that, given the large 
amounts of plaques in certain areas, it has been hypothesized that microglia remove Aβ plaques 
and travel to ventricular areas in order to deposit the plaques (Tuppo & Arias, 2005). 
Besides removing external molecules, microglia also participate in extracellular signaling 
by releasing molecules such as cytokines in order to induce cascade reactions. Cytokines are a 
broad class of proteins that primarily signal between cells. IFN- γ (interferon gamma) and TNF-α 
(tumor necrosis factor alpha) are two such molecules, responsible for rapid activation of nearby 
microglia and neuronal apoptosis, respectively. In addition to cytokines, macrophage 
inflammatory proteins are also produced by microglia, signaling a site of cleanup to macrophages 
outside of the nervous system, which can cross the blood brain barrier and aid in phagocytosis. 
Most importantly, chronic inflammation causes microglial generation of ROS, contributing to 
oxidative stress damage in the brain (Fialkow, Wang, & Downey, 2006).  
 Astrocytes are the most commonly found cell in the brain. Much like microglial cells, they 
play an important role in supporting and protecting neuronal function. Seen as the main support 
cell for neurons, these star-shaped glial cells modulate synaptic strength, provide metabolic 
support, release and uptake neurotransmitters, and promote myelination of oligodendrocytes, 
among other important tasks. Astrocytes release cytokines and neurotrophins which trigger 
immune cell entry into the central nervous system. The role of astrocytes is not fully understood, 
and future investigation is required to precisely pinpoint their role in AD development.   
 
 Radiation Effects on the CNS 
 
 It is important to note that the mechanism through which radiation can induce apoptosis in 
the developed CNS is not well understood (Belka et al., 2001). However, it has been determined 
that ionizing radiation’s high energy particles can cause damage to the CNS in a few different 
ways. The first is through the process of neuroinflammation. As stated in previous sections, chronic 
neuroinflammation is the long-term activation of microglial cells and astrocytes. The increase in 
activity of glial cells due to radiation parallels the neuroinflammation seen in the normal aging 
process, and, much like normal senescence, causes an increase in production of ROS and RNS 
(Huang, Zou, & Corniola, 2012).These free radicals go on to react with intracellular proteins, lipids 
found in neuronal membranes, as well as DNA and mtDNA.  Perforation of neuronal membranes, 
if severe enough, can lead to apoptosis. The deletion and mutation of mtDNA in some cases can 
also cause cell death, but damaged mtDNA can, more importantly, create inefficiencies in 
mitochondrial function that leads to production of more ROS/RNS (Finkel & Holbrook, 2000). 
This mtDNA-driven oxidative stress induced in neurons is not only able to spread to nearby 
unaffected cells, but also has the ability inhibit mtDNA repair pathways (Azzam, Jay-Gerin, & 
Pain, 2012). ROS and RNS can also cause DNA damage through depurinations and 
depyrimidations, as well as through base pair oxidations (Azzam et. al, 2012). These DNA 
mutations can essentially lead to apoptosis. 
Aside from the processes of neuroinflammation and oxidative stress, tau 
hyperphosphorylation (Li et. al, 2014), Aβ plaque accumulation (Cherry et al., 2012), dendritic 
spine thinning (Raber et. al, 2016), and demyelination (Panagiotakos et al., 2007) can also occur 
as a result of radiation. Changes in gene expression have been demonstrated in rat models as a 
result of low-dose ionizing radiation, with evidence pointing towards altered signaling pathways 
in axon architecture, blood vessel formation, metabolism, neuroplasticity, memory, learning, and 
LTP/LTD (Lowe et al., 2009). At 0.1 Gy exposure to gamma rays, affected genes had roles in 
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synaptic signaling and glutamate transmission, though it remains to be seen whether there are long-
term implications for such changes (Yin et al., 2003). Increased Aβ plaque deposition levels and 
tau tangle formation, too, are significant given the two proteins’ neuropathological relevance in 
AD.  
 Dendritic spines have been found to be affected by low-dose ionizing radiation. Found on 
dendrites in the CNS, dendritic spines are crucial to the processes of learning and memory and are 
responsible for excitatory synapses. Sparsity of dendritic spines is seen in patients with intellectual 
impairment. Studies have found that murine dendritic complexity decreases as a result of 1 Gy of 
gamma radiation, a trend that continues at least one-month post-irradiation (Parihar & Limoli, 
2013). Both the number and the density of dendritic spines show a dose-dependent reduction one 
month after radiation. These morphological changes could lead to deficits in learning and memory 
and decreased synaptic strength and plasticity even long after irradiation has occurred. 
Late onset demyelination, too, has been seen as a result of high doses of x-ray radiation 
(Hodges et al., 1998; Panagiotakos et al., 2007). The mechanism of this process is unknown, but a 
hypothesis is that oligodendrocytes (which make up the myelin sheath in neurons in the CNS), 
though not outwardly damaged by ionizing radiation, inherently carry genetic damage that leads 
to instability in oligodendrocyte progeny, leading to demyelination of CNS neurons that occurs 
significantly after irradiation (Panagiotakos et al., 2007).  Demyelination has been linked to MCI, 
AD, and is associated with deficits in associative and categorical learning and memory encoding 
and retrieval (Bouhrara et al., 2018).  
Radiation has also been implicated in decreased neurogenesis. Adult neurogenesis occurs 
in two places: the sub-granular zone (SGZ) of the dentate gyrus and the sub-ventricular zone (SVZ) 
found near the olfactory bulb. The former area is more frequently studied due to its location in the 
hippocampus, the center for learning and memory. As radiation tends to affect proliferating cells 
more adversely, these two areas of the brain, which actively produce neurons, are extremely 
sensitive to the effects of radiation (Huang et al., 2012). The role of neurogenesis in AD onset and 
progression is unclear, with some papers concluding that there is a deficit in neurogenesis, while 
others find that neurogenesis contrarily increases. To resolve these opposing findings, it has been 
postulated that different stages of AD correspond with different rates of neurogenesis: whereas 
early stage AD patients exhibit decreased levels of neurogenesis, mid to late stage AD patients 
experience increased rates of neurogenesis to compensate for mass neuronal death (Mu and Gage, 
2011). Regardless, it is clear that neurogenesis rates are affected by ionizing radiation and that 
change in neurogenesis is, in one way or another, associated with AD.   
 
Adverse Outcome Pathway (AOP) 
 
Given the aforementioned events that occur as a result of ionizing radiation, the following 
AOP is proposed. Figure 1 encompasses the three main hypothesizes backing AD development 
(Beta Amyloid, neuroinflammation, and oxidative stress) as well as the other processes and 
changes that occur as a result of exposure to ionizing radiation at low doses. The pathway is, of 
course, incomplete given the complexity of AD and neurodegeneration and the many unknowns 
surrounding the effects of ionizing radiation. It is, however, a good starting point in unraveling 
one of many risks that underlie the future of space travel.  
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Figure 1. AOP for Space Radiation Induced Alzheimer’s Disease 
 
 An adverse outcome pathway is a structured representation of a series of biological events 
beginning with a molecular initiating event and ending with an adverse outcome.  Causally 
connected key events are linked together with key event relationships.  Key events progress from 
simple to complex in biological organization, for example from sub-cellular to cellular to tissue to 
organ system to an adverse outcome to the organism.  The adverse outcome is typically defined 
by a regulatory requirement in either individuals or populations.  Key events are evaluated for 
essentiality which relates whether the downstream key events or adverse outcome are prevented if 
an upstream key event is blocked. Key event relationships are evaluated for biological plausibility 
and how well the mechanistic relationships of the pathway are understood.  That is to say, how 
well one can predict what changes when the pathway is disturbed. (Bal-Price & Meek, 2017) 
 Figure 1 presents the adverse outcome pathways that have been identified which link 
ionizing radiation exposure to Alzheimer’s disease. As multiple pathways may contribute to the 
advancement from radiation insult to disease, the full scope of the current understanding regarding 
the key events and key event relationships are shown in single figure.  
Table 1 presents the level of evidence for each key event relationship for the adverse 
outcome pathway shown in Figure 1, along with comments, and references for the specific 
evidence.   
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Table 1. Key Event Relationships for Adverse Outcome Pathway for Space Radiation Induced Alzheimer’s Disease 
Key Event 
relationships 
Evidence Level Notes Papers 
Ionizing Radiation 
to Subgranular 
Zone damage 
A in vivo rat 
B in vivo rat, in vitro human 
C in vivo rat, in vivo mouse, 
in vivo human (high-dose) 
--- Hodges et al., 
1998A; 
Panagiotakos et 
al., 2007B; 
Huang et al., 
2012C 
Ionizing Radiation 
to Gene expression 
modification 
D in vivo mouse 
E in vivo mouse  
altered signaling 
pathways in axon 
architecture, blood 
vessel formation, 
metabolism, 
neuroplasticity, 
memory, learning, and 
LTP/LTD 
Lowe et al., 
2009 D;  
Yin et al., 
2003E 
Ionizing Radiation 
to ROS/RNS  
in vivo rat, in vivo mouse, 
in vivo human (high-dose) 
--- Huang, et al., 
2012 
Ionizing Radiation 
to sustained 
activation of 
microglia 
C in vivo rat, in vivo mouse, 
in vivo human (high-dose) 
F in vitro human, in vivo 
human (high dose)  
--- Huang, et al., 
2012C; 
Azzam, et al., 
2012F 
Subgranular Zone 
damage to 
decreased 
neurogenesis 
in vivo rats, in vivo mouse, 
in vivo human (high-dose) 
--- Huang et al., 
2012 
Subgranular Zone 
damage to 
demyelination 
In vivo rat, in vitro human --- Panagiotakos et 
al., 2007 
Gene expression 
modification to Aβ 
plaque production 
and buildup  
--- Aβ production is 
triggered by the 
Amyloid Precursor 
Protein 
Bear et. al, 
2009 
Gene expression 
modification to 
cell death  
--- Assumption that DNA 
mutations will trigger 
preprogrammed 
apoptosis 
--- 
ROS/RNS to Gene 
expression 
modification 
in vitro human, in vivo 
human (high dose) 
--- Azzam et. al, 
2012 
ROS/RNS to 
PUFA 
peroxidation 
In vitro human, in vivo 
mice 
--- Finkel & 
Holbrook, 2000 
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ROS/RNS to 
mtDNA 
modification  
G in vivo human 
F in vitro human, in vivo 
human (high dose) 
--- Indo et al., 
2007G;  
Azzam, et al., 
2012 F 
Sustained 
activation of 
microglia to 
ROS/RNS 
C in vivo rat, in vivo mice, 
in vivo human (high-dose) 
H in vitro human 
--- Huang, et al., 
2012C 
Fialkow, et al., 
2006 H 
Demyelination to 
weakened 
synapses  
--- Neurobiology basis; 
Demyelination leads to 
reduced conduction 
velocity 
Bear et al., 
2009 
Dendritic spine 
thinning to fewer 
excitatory 
synapses 
--- Neurobiology basis; 
Demyelination leads to 
reduced conduction 
velocity due to 
protective qualities of 
fat  
Bear et al., 
2009 
Aβ production and 
buildup to tau 
protein 
hyperphosphorylat
ion  
--- Neurobiology basis; 
Aβ/Tau tangle theory of 
AD, Aβ plaques do not 
lead to tau tangle 
formation, but the two 
events are highly 
correlated, and are 
considered to be the 
hallmarks of AD.  
Bear et al., 
2009 
Aβ production and 
buildup to 
sustained 
activation of 
microglia  
In vitro human, in vivo rats --- Tuppo & Arias, 
2005 
PUFA 
peroxidation to 
cell death  
I in vivo human   
Fin vitro human, in vivo 
human (high dose) 
--- Pratico & Sung, 
2004I 
Azzam et al., 
2012F 
Weakened 
synapses to 
decreased 
LTP/LTD 
--- Neurobiology basis; 
LTP/LTD depends on 
synaptic strength at 
NMDA and AMPA 
receptors 
Bear et al., 
2009 
Fewer excitatory 
synapses to 
decreased 
LTP/LTD 
--- Neurobiology basis; 
LTP/LTD depends on 
synaptic strength at 
NMDA and AMPA 
receptors 
Bear et al., 
2009 
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Tau protein 
hyperphosphorylat
ion to cerebral 
atrophy  
--- Neurobiology basis; 
Aβ/Tau tangle theory of 
AD, which states that 
tau tangles are directly 
correlated with neuronal 
death due to structural 
damage 
Bear et al., 
2009 
Cell death to 
cerebral atrophy  
--- Definition of atrophy is 
mass cell death 
--- 
mtDNA mutation 
to cell death  
--- Assumption that 
mtDNA mutations will 
trigger preprogrammed 
apoptosis  
--- 
mtDNA mutation 
to ROS/RNS (and 
vice versa) 
in vivo human  --- Indo et al., 2007 
Decreased 
LTP/LTD to 
decreased 
neuroplasticity  
--- Neurobiology basis; 
Based on current theory 
that LTP/LTD are 
fundamental to learning 
processes and synaptic 
modulation processes 
fundamental to the 
concept of 
neuroplasticity. 
Bear et al., 
2009 
Cerebral Atrophy 
to Lack of 
temporal/spatial 
awareness 
--- Loss of neurons in 
temporal lobe and 
hippocampus lead to 
hippocampus 
dysfunction; 
hippocampus is 
responsible for temporal 
and spatial awareness 
--- 
Cerebral Atrophy 
to dementia 
--- Loss of neurons and 
neuronal connection 
leads to cerebellar 
dysfunction.  
--- 
Cerebral Atrophy 
to deficits to 
executive function 
--- Loss of neurons in 
prefrontal cortex and 
frontal lobe lead to 
malfunction of frontal 
lobe, which is 
responsible for higher-
level function 
--- 
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Decreased 
neuroplasticity to 
decreased learning 
--- Neurobiology basis; 
based on current theory 
that neuroplasticity 
underlies our learning 
processes 
Bear et al., 
2009 
 
 
 
Discussion 
 
Much of the proposed adverse outcome pathway is based on in vivo rat and mouse data. It 
should be acknowledged that these models, though reliable, should be carefully considered in 
terms of translation to human expression. Secondly, note that many of the events in the pathway 
have neurobiological or neurocognitive foundations. It is fair to assume that the delicate balance 
of the neural environment can be disrupted by events such as imbalance in neurovascular structure, 
protein misfolding, and cellular atrophy. More complicated cognitive processes in the brain such 
as learning and memory, which we are still only beginning to understand, outwardly rely on 
neurobiological functions such as LTP and LTD.  Though it is generally agreed upon in the fields 
of neuroscience and cognitive sciences how such processes underlie critical neurological function, 
these neurobiological underpinnings remain hypothetical in nature and require further study.  
Cognitively speaking, it is well established that loss of grey and white matter leads to 
dysfunction of the brain area affected by the atrophy. Although specific cognitive functions cannot 
be completely isolated to just one portion of the brain, it has been identified that certain neural 
connections in the brain are more relevant for certain cognitive functions than others. The 
hippocampus, for example, is a local site of cognitive functions such as episodic memory and 
spatial awareness, and lesions to this bilateral structure found in the temporal lobe lead to marked 
deficits on tasks that require such functions. Another example of this is the frontal lobe, where the 
cognitive skills of executive function have been found to be localized. Damage to this region has 
been inexplicably linked to deficits on tasks such as the Wisconsin Card Sorting Task and the 
Stroop task. The linkage of such deficits due to low-dose radiation to a diagnosis of Alzheimer’s 
is useful in its implications for radiation sources on Earth, as well as in its pathology, which could 
hold more clues to the treatment of Alzheimer’s.  
 
Summary 
 
 It should be noted that there are a few caveats for an adverse outcome pathway relating 
low-dose ionizing radiation to AD development. Firstly, it is important to note that although some 
arrows in the diagram are causal, others are only correlational. This can be attributed to the fact 
that there remains no answer to the question of what causes AD. Though it is hypothesized that 
factors such as Aβ plaque production, neuroinflammation, and oxidative stress all contribute to the 
neurodegenerative disorder, efforts to inhibit the aforementioned processes have not stopped, or 
even slowed, the progression of the disease. A concrete example of a correlational (rather than 
causal) relationship can be seen in the middle of the pathway, which shows the module of “Aβ 
production and buildup” leading to “tau protein hyperphosphorylation”. Aβ protein accumulation 
does not cause tau protein hyperphosphorylation, but the two are very clearly correlated, not only 
with each other, but also with the progression of AD as a whole. AD, currently, does not have a 
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cure, nor does it have a definitive cause. The modules on the left side of the pathway certainly 
contribute to the changes seen on the right side of the pathway, and it is true that these functional 
changes lead to the cognitive deficits seen in AD, but efforts to halt both earlier and later processes 
have not proven to be beneficial to AD patients.  
Secondly, rat models, non-human primate (NHP) models, and human in vitro models are 
not wholly accurate representations of the in vivo cellular responses seen in humans as a result of 
ionizing radiation. Though trends in these models may accurately reflect the cellular responses of 
radiation on humans, they may not be entirely correct and require careful extrapolation and 
analysis. Neurological changes observed in irradiated rats is only a semi-comparable way of 
analyzing cognition, as behavioral neuroscience is not a replacement for cognitive neuroscience.  
 Along the same vein, it is important to note the differences in environments between rat 
models and human astronauts. Space radiation is made of many different particles for sustained 
periods of time, with different amounts of energy associated with different types of exposure to 
radiation. The barrage of naturally occurring high energy particles of space radiation have been 
modeled through 56Fe, 137Cs, and other particles within the lab, as it is almost impossible to recreate 
a true space-radiation environment in a lab. Recent efforts at the NASA Space Radiation 
Laboratory (NSRL) to develop the Galactic Cosmic Ray Simulator (GCRsim) were done to 
address some of these concerns (Norbury et al., 2016).  The NSRL GCRsim facility conducted the 
first full exposures to animals in the Fall of 2018, so results are anticipated in the near future. That 
being said, the assumption that a lab created environment accurately mirrors the true space 
environment could lead to possible erroneous conclusions. 
 Extensive research done on rats, NHP, and in vitro levels within laboratories remains 
fundamental in beginning to uncover the effects of low-dose ionizing radiation on the nervous 
system as a whole. The theories, pathways, and models created as a result of these studies are 
highly necessary in understanding the risks astronauts are exposed to as they undergo missions to 
space. Increasing the amount of data is the only way to accurately predict radiation thresholds for 
safe space travel. Acute nervous system damage is significantly better understood than long-term 
CNS damage, but the latter should certainly be accounted for when planning further space missions. 
 In addition, on the pure neuroscience front, additional research on the effects of ionizing 
radiation should continue. Neuroinflammation, oxidative stress, and neurogenesis are processes 
affected by both aging and radiation, and the related biological and cellular factors of the events 
are still not well known. These deeply complicated processes are interlocked in ways that remain 
occluded to researchers in every discipline and require further investigation. The glutamatergic 
system, as well as the cerebrovascular system, have been found to be altered in AD patients, as 
well as in dementia patients. There remains little to no literature regarding the effects of low-dose 
ionizing radiation on the two aforementioned systems, and future studies should seek to correlate 
changes in the blood brain barrier, microvascular system, and glutamate receptors with radiation 
at <1 Gy.  
Lastly, an understanding of Alzheimer’s (as well as other neurodegenerative diseases) on 
behavioral, cognitive, and neuropathological levels remains insufficient to create causal linkages 
between symptomatic and underlying biological events. More studies are needed to fully uncover 
details regarding Alzheimer’s, including but not limited to topics such as the glutamatergic system, 
vascular changes, and possible inhibitory processes to reduce these neuropathological damages 
from occurring in the first place. Interdisciplinary research is required for true quantitative analysis.   
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